CIPLA LTD
CIPLA.NS
₹ 1,031.30
0%

Cipla Ltd

Cipla Ltd is a Small Cap stock that belongs to the Pharmaceuticals & Drugs sector. The current live share price of Cipla is ₹ 1,031.30 that is ₹ 1.50 0.15% with respect to the previous day’s close price. The stock price of Cipla was last updated 55 mins ago.

Cipla Stock Price Performance

In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.

Cipla Live Share Price Analysis

CIPLA LTD
₹ 1,031.30
Open ₹ 1,029.80
High ₹ 1,034.85
Marketcap 832.61B
Close ₹ 1,031.30
Low ₹ 1,021.30
Volume ₹ 965,313.00

The stock of Cipla Ltd strated the trade at an Open price of ₹ 1,029.80 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 1,034.85 and an Intraday Low price of ₹ 1,021.30%. As per last updated 55 mins ago, the Shares of Cipla were trading at a price of ₹ 1,031.30 which is ₹ 1.50 0.15% as compared the price ₹ 1,029.80 at which the stock close on the previous trading day. The total traded volume for the day stood at 965,313 number of shares.

Candlestick Chart of Cipla Share Price Movements

The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).

Historical Performance of Cipla Shares

52 Week RangePrice52 Weeks Low52 Weeks High
₹ 1,031.30₹ 888.15₹ 1,185.25

Here is Cipla’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 1,185.25. On the lower side, the stock has been to the 52 weeks low price level of ₹ 888.15. It’s last traded price was ₹ 1,031.30 as on last update 55 mins ago. The one-year line chart clearly shows how the price of Cipla’s stock has moved in the last twelve months.

The Company has posted an earnings of ₹ 27.709 per share (EPS TTM) in the trailing twelve months period. Cipla’s last annual dividend rate was %, which translates to a % of annual dividend yield.

Line Chart of Cipla Stock Price

Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.

Companies Similar to Cipla

Cipla Ltd belongs to the Pharmaceuticals & Drugs sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to Cipla are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.

Share Price Snapshot Companies Similar to Cipla

Select list of companies is given below. To view more about the Industry and see other companies from Industry, click on the industry name.
ALEMBICLTD.NSALEMBIC LTD
₹ 66.55
NSE
₹ 0.3
0.45%

About Cipla

Cipla Ltd is a Cipla Group Company. The company operates in the Pharmaceuticals & Drugs sector. It is a holding company. Incorporated in 1935, it has around 86 years of operations. Cipla live share price is ₹ 1,031.30. It is a Small Cap stock and had a market capitalization of ₹ 832,608,731,136.00 as on 55 mins ago.

  • Cipla is a pharmaceutical company.
  • The Company’s strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access.
  • The Company’s geographical segments include India, USA, South Africa and Rest of the World.
  • The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health.
  • The Company offers its products for the therapeutic areas, including cardiovascular, children’s health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women’s health.

The registered office of Cipla is located in Mumbai, Maharashtra. The registrar and share transfer agent for Cipla is K FIN Technologies Pvt Ltd. The Stock Exchanges on which shares of Cipla Ltd is listed includes BSE, NSE, Luxembourg, MCX.

CIPLA LTD
Status: Active
Sector: Healthcare
Industry: Drug Manufacturers—General
Employees: 25927
Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. It also provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Cipla Limited has a licensing agreement with Merck & Co., Inc. for the manufacturing and distribution of Molnupiravir, an investigational oral antiviral drug; a license agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib for Covid-19 indication; and collaborations with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for the clinical trial of the investigational oral anti-viral drug Molnupiravir. The company was incorporated in 1935 and is headquartered in Mumbai, India.
AddressCipla House, Mumbai, India
CountryIndia
Phone91 22 2482 6000
Websitehttps://www.cipla.com

Cipla Recent News

No Recent News found for Cipla Ltd.